HealthDay - SUNDAY, Aug. 30 (HealthDay News) -- A new anti-clotting drug,
ticagrelor (Brilinta), was better than than clopidogrel (Plavix) in
preventing new heart attacks and in reducing deaths among profession who
have had a heart attack, a new study finds.

More: - Read More